Last update 08 May 2025

NKG2A x CD3 x 5T4

Basic Info

Related Targets
NKG2ACD35T4

Related

1
Drugs associated with NKG2A x CD3 x 5T4
IM1240
Target
5T4 x CD3 x NKG2A
Mechanism
5T4 inhibitors [+2]
Active Org.
Purple Biotech Ltd.Purple Biotech Ltd.
Originator Org.
Purple Biotech Ltd.Purple Biotech Ltd.
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with NKG2A x CD3 x 5T4
Login to view more data
100 Translational Medicine associated with NKG2A x CD3 x 5T4
Login to view more data
0 Patents (Medical) associated with NKG2A x CD3 x 5T4
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free